News

Innovative Partnership Enhances CBD IV Therapy Approach

Innovative Partnership Enhances CBD IV Therapy Approach

Innovative Partnership Enhances CBD IV Therapy

PICO IV, known for introducing the world's first sterile CBD emulsion, has formed a strategic partnership with Liquivida, a leader in IV therapy and wellness solutions. This collaboration aims to push the boundaries of IV hydration while ensuring top-tier safety and educational standards. As health and wellness innovations continue to expand, this partnership marks a significant leap forward for both entities.

Sam Tejada Joins as Spokesperson

In a notable development, Liquivida's founder, Sam Tejada, who is also the Chairman of the Leadership Advisory Board for the American IV Association (AIVA), has been appointed to the PICO IV Advisory Board. Tejada’s role as a spokesperson is crucial, as he will advocate for the medicinal capabilities of CBD and inform the public about the endocannabinoid system (ECS), a vital regulatory network that supports overall health.

Insights from Sam Tejada

"This isn't just a new product, it's the beginning of a new category of treatment," Tejada stated passionately. He highlighted, "At Liquivida, we're very selective about what we incorporate into our clinics, and PICO IV exemplifies the highest standards of safety, scientific backing, and purpose. We are thrilled about the implications this holds for the future of IV therapy and patient health."

The Advancement of CBD Technology

Selecting effective methods of delivering CBD has gained momentum, particularly since legislative changes in recent years. However, traditional oral and topical applications can fall short, as only a fraction of CBD is effectively absorbed. Through its innovative technology, PICO IV has transformed CBD into finer particles, referred to as 'pico', enhancing absorption rates and bioavailability to nearly 100%. This groundbreaking approach allows for more precise dosing and quick systemic effects, vital for both clinical environments and performance-oriented applications.

Commitment to Safety and Purity

PICO IV stands out as the first and only company to offer CBD in a sterile solution format. Their products are manufactured in a cGMP facility and are subject to rigorous testing. Utilizing e-beam sterilization ensures a contamination-free product, without compromising its quality. Joe Young, the Chief Executive Officer at PICO IV, said, "We are keenly aware of the responsibilities that come with introducing sterile CBD to the market. Safety is our utmost priority, and we have taken meticulous measures throughout our manufacturing process to ensure every product is trustworthy."

Education on the Endocannabinoid System

A fundamental aim of this partnership is to foster greater understanding of the ECS among healthcare providers. This system, while essential for overall health maintenance, is often overlooked in conventional medical training. Liquivida is committed to enabling education among its affiliate doctors and their patients regarding the ECS, adding to the growing body of knowledge around sterile CBD and its integration into clinical practices.

As the sciences surrounding CBD and IV therapy evolve, Liquivida will play a pivotal role in equipping its nationwide network of healthcare professionals with knowledge about this system and the potential benefits of PICO IV. This shared mission ensures that accessible and scientifically grounded wellness solutions are available to a broader audience.

Both PICO IV and Liquivida are stepping into a transformative period, characterized by increasing interest in advanced wellness options. As practitioners look for evidence-based solutions that amalgamate natural healing with clinical integrity, this partnership will undoubtedly pave the way for a more thorough understanding of and access to these therapies.

About PICO IV

PICO IV specializes in the development of the world's first sterile CBD solution, which adheres to FDA-approved filtration standards. Their flagship formula delivers cannabinoids with unparalleled purity and precision.

About Liquivida

Liquivida is a prominent wellness franchise that combines scientific principles with self-care approaches, offering a range of services including IV therapy, weight loss programs, hormone health, and regenerative therapies, all designed to empower individuals to lead healthier lifestyles.

Frequently Asked Questions

What is the significance of PICO IV's partnership with Liquivida?

The partnership aims to advance IV hydration methods while educating both providers and patients on the benefits of sterile CBD.

Who is Sam Tejada and what role does he play?

Sam Tejada is the founder of Liquivida, appointed as a spokesperson for PICO IV to raise awareness about CBD's clinical potential.

How does PICO IV's technology enhance CBD absorption?

PICO IV's technology reduces CBD particle size, allowing for nearly 100% bioavailability and more efficient absorption through IV delivery.

What facilities are involved in PICO IV's manufacturing process?

PICO IV produces its sterile CBD solution in a cGMP facility, ensuring rigorous quality and safety standards are met.

Why is education on the endocannabinoid system important?

Understanding the ECS is essential for health providers to effectively integrate CBD therapies into clinical practices, enhancing patient care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 25

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 142

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 115

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 81

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 177

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 98

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 115

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 83

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Specialty Chemicals Need Demand Before Capacity Bets

Updated Category News Views 96

Empty reactor space does not get filled because everybody suddenly loves reshoring. SOCMA's 2027 Contract Manufacturing Outlook makes that stubborn fact hard to dodge: nearly 70% of surveyed respondents expect North American manufacturing activity to rise over the next three years, yet 79.5% say stronger, more predictable customer demand is critical before future...

Continue Reading

Top 5 Most Recently Viewed Articles

New Terminal One Partners with Plaza Premium to Elevate Travel

Updated Category News Views 234

New Terminal One & Plaza Premium Group Collaboration The New Terminal One at JFK International Airport has joined forces with Plaza Premium Group (PPG), a leading name in airport hospitality, to create two state-of-the-art lounges. Together, they aim to transform the travel experience at this vital international hub, covering close to 14,000 square feet and promising...

Continue Reading
Market Update: S&P 500 Fluctuates After Holiday Trading

Updated Category News Views 337

S&P 500 Experiences Mixed Results in Light Trading The recent trading session saw the S&P 500 close on a flat note after a day of ups and downs, all in the backdrop of lower-than-usual trading volumes, a trend typical of the holiday breakout. As of the market close, the S&P 500 had dipped by 0.1%, while the NASDAQ Composite mirrored this decrease. In contrast, the Dow...

Continue Reading
Brand Engagement Network Expands Horizons with Cataneo Acquisition

Updated Category News Views 104

Brand Engagement Network Expands Strategic Capabilities Jackson, Wyo. – brand Engagement Network, Inc. (NASDAQ: BNAI) has recently made headlines by agreeing to acquire a German media technology powerhouse, Cataneo Gmbh. This acquisition not only highlights BEN's commitment to growth but also demonstrates its ambition to transform how brands use AI to engage with their...

Continue Reading
Metagenomi Showcases Advanced Adenine Base Editors for Gene Therapy

Updated Category News Views 195

Introducing Metagenomi's Innovative Adenine Base Editors Metagenomi has unveiled its cutting-edge Adenine Base Editors (ABEs) at a recent event, highlighting their impressive capabilities in genome editing. These novel tools achieved over 95% targetability in gene modification, demonstrating exceptional performance and efficiency. Key Highlights from the Presentation...

Continue Reading
Streamlining IT Procurement: SysAid Launches on AWS Marketplace

Updated Category News Views 49

SysAid Now Accessible via AWS Marketplace SysAid, a leading Enterprise and IT Service Management solution provider, has made an exciting announcement regarding its availability on AWS Marketplace. This curated digital catalog is designed to simplify the process of discovering, procuring, and deploying software solutions. With AWS Marketplace having over 290,000 active...

Continue Reading